KalVista Pharmaceuticals Inc
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
10.49
0.14
(1.353%)
Volume:
363,774
52 week range:
7.21 - 16.88
Market Cap:
442.555M
Company Description:
kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.